These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 10914726

  • 1. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA.
    Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
    [Abstract] [Full Text] [Related]

  • 2. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.
    Koene G, Mulder A, van der Ven K, Eijsink C, Franke M, Slootweg P, Claas F, Tilanus M.
    Hum Immunol; 2006 Sep; 67(9):692-9. PubMed ID: 17002899
    [Abstract] [Full Text] [Related]

  • 3. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ, Arts-Hilkes YH, van Dijk AJ, van der Ven KJ, Slootweg PJ, de Weger RA, Tilanus MG.
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y, Zhang J, Miao F, Wei J, Shen C, Shen Y, Xie W.
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [Abstract] [Full Text] [Related]

  • 5. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL.
    Cancer Res; 2005 Dec 01; 65(23):11146-55. PubMed ID: 16322265
    [Abstract] [Full Text] [Related]

  • 7. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M, Pauli C, Stein M, Chaubal S, Wollenberg B.
    Anticancer Res; 2003 Dec 01; 23(2B):1467-71. PubMed ID: 12820411
    [Abstract] [Full Text] [Related]

  • 8. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
    Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S, Strome SE.
    Cancer; 2003 May 01; 97(9):2203-11. PubMed ID: 12712472
    [Abstract] [Full Text] [Related]

  • 9. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May 01; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 10. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S.
    Clin Cancer Res; 2003 Sep 15; 9(11):4043-51. PubMed ID: 14519625
    [Abstract] [Full Text] [Related]

  • 11. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.
    Br J Dermatol; 2008 May 15; 158(5):930-40. PubMed ID: 18284388
    [Abstract] [Full Text] [Related]

  • 12. Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
    Mandic R, Lieder A, Sadowski M, Peldszus R, Werner JA.
    Anticancer Res; 2004 May 15; 24(2B):973-9. PubMed ID: 15161052
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy for head and neck cancer.
    Gleich LL.
    Laryngoscope; 2000 May 15; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [Abstract] [Full Text] [Related]

  • 14. HLA and MICA associations with head and neck squamous cell carcinoma.
    Reinders J, Rozemuller EH, Otten HG, van der Veken LT, Slootweg PJ, Tilanus MG.
    Oral Oncol; 2007 Mar 15; 43(3):232-40. PubMed ID: 16857416
    [Abstract] [Full Text] [Related]

  • 15. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
    Visus C, Ito D, Amoscato A, Maciejewska-Franczak M, Abdelsalem A, Dhir R, Shin DM, Donnenberg VS, Whiteside TL, DeLeo AB.
    Cancer Res; 2007 Nov 01; 67(21):10538-45. PubMed ID: 17974998
    [Abstract] [Full Text] [Related]

  • 16. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
    Ferris RL, Whiteside TL, Ferrone S.
    Clin Cancer Res; 2006 Jul 01; 12(13):3890-5. PubMed ID: 16818683
    [Abstract] [Full Text] [Related]

  • 17. Loss of HLA class I expression in prostate cancer: implications for immunotherapy.
    Blades RA, Keating PJ, McWilliam LJ, George NJ, Stern PL.
    Urology; 1995 Nov 01; 46(5):681-6; discussion 686-7. PubMed ID: 7495121
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN, Gorter A, Fleuren GJ, Oosting J, Uljee S, ter Haar N, Dreef EJ, Kenter GG, Jordanova ES.
    J Pathol; 2008 Jul 01; 215(3):222-30. PubMed ID: 18438953
    [Abstract] [Full Text] [Related]

  • 19. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M, Bier H, Schirlau K, Friebe-Hoffmann U, Scheckenbach K, Balz V, Whiteside TL, Hoffmann TK.
    Oral Oncol; 2006 Aug 01; 42(7):691-7. PubMed ID: 16527515
    [Abstract] [Full Text] [Related]

  • 20. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL, Mamede RC, Proto-Siqueira R, Neder L, Silva WA, Zago MA.
    Head Neck; 2006 Jul 01; 28(7):614-9. PubMed ID: 16475205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.